Hologic Historical Balance Sheet
HOLX Stock | USD 61.47 0.46 0.75% |
Trend analysis of Hologic balance sheet accounts such as Total Current Liabilities of 1.3 B or Total Stockholder Equity of 6.2 B provides information on Hologic's total assets, liabilities, and equity, which is the actual value of Hologic to its prevalent stockholders. By breaking down trends over time using Hologic balance sheet statements, investors will see what precisely the company owns and what it owes to creditors or other parties at the end of each accounting year.
Financial Statement Analysis is much more than just reviewing and examining Hologic latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Hologic is a good buy for the upcoming year.
Hologic Inventory |
|
Hologic |
About Hologic Balance Sheet Analysis
Balance Sheet is a snapshot of the financial position of Hologic at a specified time, usually calculated after every quarter, six months, or one year. Hologic Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Hologic and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Hologic currently owns. An asset can also be divided into two categories, current and non-current.
Hologic Balance Sheet Chart
Add Fundamental
Total Assets
Total assets refers to the total amount of Hologic assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Hologic books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.Total Current Liabilities
Total Current Liabilities is an item on Hologic balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Hologic are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. The total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations.Total Stockholder Equity
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders.Property Plant And Equipment Net
The total value of a company's physical assets (such as land, buildings, and equipment) used in operations, net of depreciation. It reflects the company's investment in assets used for production.Most accounts from Hologic's balance sheet are interrelated and interconnected. However, analyzing balance sheet accounts one by one will only give a small insight into Hologic current financial condition. On the other hand, looking into the entire matrix of balance sheet accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Hologic. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of economic analysis. For more information on how to buy Hologic Stock please use our How to Invest in Hologic guide.At this time, Hologic's Inventory is fairly stable compared to the past year. Other Stockholder Equity is likely to rise to about 6.3 B in 2025, whereas Short and Long Term Debt Total is likely to drop slightly above 1.9 B in 2025.
2022 | 2023 | 2024 | 2025 (projected) | Short and Long Term Debt Total | 2.8B | 2.7B | 3.1B | 1.9B | Total Assets | 9.1B | 9.2B | 10.5B | 11.1B |
Hologic balance sheet Correlations
Click cells to compare fundamentals
Hologic Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Hologic balance sheet Accounts
2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
Total Assets | 8.9B | 9.1B | 9.1B | 9.2B | 10.5B | 11.1B | |
Short Long Term Debt Total | 3.0B | 2.8B | 2.8B | 2.7B | 3.1B | 1.9B | |
Total Current Liabilities | 1.3B | 937.7M | 1.2B | 1.0B | 1.2B | 1.3B | |
Total Stockholder Equity | 4.2B | 4.9B | 5.0B | 5.1B | 5.9B | 6.2B | |
Property Plant And Equipment Net | 564.7M | 481.6M | 517M | 537.8M | 618.5M | 649.4M | |
Net Debt | 1.9B | 483.9M | 95.7M | 497.8M | 572.5M | 1.1B | |
Retained Earnings | 298.3M | 1.6B | 2.1B | 2.8B | 2.6B | 2.7B | |
Cash | 1.2B | 2.3B | 2.7B | 2.2B | 2.5B | 2.6B | |
Non Current Assets Total | 5.8B | 5.2B | 5.0B | 5.3B | 6.1B | 3.1B | |
Cash And Short Term Investments | 1.2B | 2.3B | 2.7B | 2.3B | 2.7B | 2.8B | |
Net Receivables | 942.7M | 617.6M | 625.6M | 600.4M | 690.5M | 725.0M | |
Common Stock Shares Outstanding | 259.7M | 253.8M | 248.8M | 237.6M | 273.2M | 170.5M | |
Liabilities And Stockholders Equity | 8.9B | 9.1B | 9.1B | 9.2B | 10.5B | 11.1B | |
Non Current Liabilities Total | 3.4B | 3.3B | 2.9B | 3.0B | 3.4B | 2.0B | |
Inventory | 501.2M | 623.7M | 617.6M | 679.8M | 781.8M | 820.9M | |
Other Stockholder Equity | 4.0B | 3.5B | 3.1B | 5.2B | 6.0B | 6.3B | |
Total Liab | 4.7B | 4.2B | 4.1B | 4.0B | 4.6B | 2.5B | |
Total Current Assets | 3.2B | 3.9B | 4.2B | 3.8B | 4.4B | 4.6B | |
Non Currrent Assets Other | 214.3M | 188.8M | 267.9M | 410.8M | 472.4M | 496.0M | |
Other Current Assets | 554.5M | 281.2M | 218.8M | 209.5M | 240.9M | 253.0M | |
Other Current Liab | 498.5M | 467.9M | 490.8M | 486.3M | 559.2M | 587.2M | |
Accounts Payable | 215.9M | 197.7M | 175.2M | 203.8M | 234.4M | 246.1M | |
Short Term Debt | 343.5M | 41.4M | 310.5M | 64.8M | 74.5M | 70.8M | |
Property Plant And Equipment Gross | 1.3B | 1.3B | 1.3B | 1.4B | 1.6B | 1.6B | |
Accumulated Other Comprehensive Income | (59.1M) | (238.2M) | (147.6M) | (111.5M) | (100.4M) | (95.3M) | |
Other Assets | 424.5M | 245.7M | 210.5M | 179M | 205.9M | 216.1M | |
Long Term Debt | 2.7B | 2.8B | 2.5B | 2.5B | 2.9B | 2.2B | |
Treasury Stock | (926M) | (1.6B) | (2.0B) | (2.5B) | (2.3B) | (2.2B) | |
Intangible Assets | 1.7B | 1.3B | 888.6M | 844.6M | 971.3M | 1.7B | |
Property Plant Equipment | 491.5M | 564.7M | 481.6M | 579.7M | 666.7M | 337.5M | |
Current Deferred Revenue | 198M | 186.5M | 199.2M | 212.9M | 244.8M | 132.4M | |
Good Will | 3.3B | 3.2B | 3.3B | 3.4B | 4.0B | 2.3B | |
Other Liab | 429.3M | 662.3M | 448.9M | 321.5M | 369.7M | 441.1M | |
Net Tangible Assets | (1.3B) | (722.2M) | 359.1M | 847M | 974.1M | 1.0B | |
Long Term Debt Total | 2.8B | 2.7B | 2.7B | 2.8B | 3.2B | 3.2B | |
Capital Surpluse | 5.8B | 5.9B | 6.0B | 6.0B | 6.9B | 6.1B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Hologic Stock Analysis
When running Hologic's price analysis, check to measure Hologic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Hologic is operating at the current time. Most of Hologic's value examination focuses on studying past and present price action to predict the probability of Hologic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Hologic's price. Additionally, you may evaluate how the addition of Hologic to your portfolios can decrease your overall portfolio volatility.